BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2151448)

  • 1. The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.
    Antimi M; Masi M; Delannoy A; Ferrant A; Doyen C; Debusscher L; Delwiche F; Stryckmans P; Papa G
    Haematologica; 1990; 75(5):443-6. PubMed ID: 2151448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.
    Koller CA; Miller DM
    N Engl J Med; 1986 Dec; 315(23):1433-8. PubMed ID: 2431313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myeloid crisis of chronic myelogenous leukemia showing dramatic response to mithramycin and hydroxyurea combination].
    Ueki K; Tsuchida A; Murakami H; Karasawa M; Kobayashi N; Omine M; Naruse T
    Rinsho Ketsueki; 1989 Oct; 30(10):1840-2. PubMed ID: 2531808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.
    Trümper LH; Ho AD; Hunstein W; van der Lelie H; Goudsmit R
    Blut; 1989 Feb; 58(2):85-7. PubMed ID: 2522015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plicamycin-hydroxyurea association in chronic granulocytic leukemia and multidrug resistance.
    Papineschi F; Carulli G; Petrini M
    Haematologica; 1991; 76(4):349. PubMed ID: 1686602
    [No Abstract]   [Full Text] [Related]  

  • 6. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of mithramycin to control the myeloid blast phase of chronic granulocytic leukemia: a report on nine patients and review of the literature.
    Johnson PR; Yin JA; Narayanan MN; Geary CG; Love EM; Cinkotai KI
    Hematol Oncol; 1991; 9(1):9-15. PubMed ID: 1828453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.
    Dutcher JP; Eudey L; Wiernik PH; Paietta E; Bennett JM; Arlin Z; Kellermeyer R; Rowe J; O'Connell M; Oken M
    Leukemia; 1992 Aug; 6(8):770-5. PubMed ID: 1379312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
    Fruehauf S; Topaly J; Buss EC; Fischer T; Ottmann OG; Emmerich B; Müller MC; Schuld P; Balleisen L; Hehlmann R; Ho AD; Hochhaus A
    Cancer; 2007 Apr; 109(8):1543-9. PubMed ID: 17340589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study.
    Meloni G; Foà R; Tosti S; Vignetti M; Gavosto F; Mandelli F
    Haematologica; 1990; 75(6):502-5. PubMed ID: 2098290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of the blast phase of chronic granulocytic leukemia with mithramycin and hydroxyurea.
    Queisser W; Herrmann F; Lindemann A; Anger B; Hiddemann W; Krey U
    Onkologie; 1988 Jun; 11(3):145-6. PubMed ID: 2970612
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia.
    Maia RC; Noronha H; Vasconcelos FC; Rumjanek VM
    Clin Lab Haematol; 1997 Sep; 19(3):215-7. PubMed ID: 9352149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated and blastic phases of chronic myelogenous leukemia.
    Giles FJ; Cortes JE; Kantarjian HM; O'Brien SM
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):753-74, xii. PubMed ID: 15271404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of blast crisis of chronic myeloid leukemia].
    Kotlarek-Haus S
    Acta Haematol Pol; 1992; 23(2 Suppl 1):23-9. PubMed ID: 1488869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [P-glycoprotein and treatment with plicamycin + hydroxyurea in myeloid blastic crisis of chronic myeloid leukemia].
    Carulli G; Marini A; Caracciolo F
    Medicina (Firenze); 1989; 9(4):409-10. PubMed ID: 2576761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic granulocytic leukemia in blastic crisis.
    Canellos GP
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.
    Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O
    Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.